JP7269568B2 - 不安障害及び／又は気分障害を改善又は予防するための組成物 - Google Patents

不安障害及び／又は気分障害を改善又は予防するための組成物 Download PDF

Info

Publication number
JP7269568B2
JP7269568B2 JP2019130105A JP2019130105A JP7269568B2 JP 7269568 B2 JP7269568 B2 JP 7269568B2 JP 2019130105 A JP2019130105 A JP 2019130105A JP 2019130105 A JP2019130105 A JP 2019130105A JP 7269568 B2 JP7269568 B2 JP 7269568B2
Authority
JP
Japan
Prior art keywords
composition
mice
enterococcus
receptor
test
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2019130105A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021014432A (ja
Inventor
謙太郎 永岡
淳 神邉
祐子 板谷
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NATIONAL UNIVERSITY CORPORATION TOKYO UNIVERSITY OF AGRICULUTURE & TECHNOLOGY
Combi Corp
Original Assignee
NATIONAL UNIVERSITY CORPORATION TOKYO UNIVERSITY OF AGRICULUTURE & TECHNOLOGY
Combi Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NATIONAL UNIVERSITY CORPORATION TOKYO UNIVERSITY OF AGRICULUTURE & TECHNOLOGY, Combi Corp filed Critical NATIONAL UNIVERSITY CORPORATION TOKYO UNIVERSITY OF AGRICULUTURE & TECHNOLOGY
Priority to JP2019130105A priority Critical patent/JP7269568B2/ja
Priority to PCT/JP2020/024878 priority patent/WO2021010118A1/fr
Priority to KR1020217038309A priority patent/KR20220034724A/ko
Publication of JP2021014432A publication Critical patent/JP2021014432A/ja
Application granted granted Critical
Publication of JP7269568B2 publication Critical patent/JP7269568B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP2019130105A 2019-07-12 2019-07-12 不安障害及び／又は気分障害を改善又は予防するための組成物 Active JP7269568B2 (ja)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP2019130105A JP7269568B2 (ja) 2019-07-12 2019-07-12 不安障害及び／又は気分障害を改善又は予防するための組成物
PCT/JP2020/024878 WO2021010118A1 (fr) 2019-07-12 2020-06-24 Composition pour l'amélioration ou la prophylaxie de troubles de l'anxiété et/ou de troubles de l'humeur
KR1020217038309A KR20220034724A (ko) 2019-07-12 2020-06-24 불안장애 및/또는 기분장애를 개선 또는 예방하기 위한 조성물

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2019130105A JP7269568B2 (ja) 2019-07-12 2019-07-12 不安障害及び／又は気分障害を改善又は予防するための組成物

Publications (2)

Publication Number Publication Date
JP2021014432A JP2021014432A (ja) 2021-02-12
JP7269568B2 true JP7269568B2 (ja) 2023-05-09

Family

ID=74210474

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019130105A Active JP7269568B2 (ja) 2019-07-12 2019-07-12 不安障害及び／又は気分障害を改善又は予防するための組成物

Country Status (3)

Country Link
JP (1) JP7269568B2 (fr)
KR (1) KR20220034724A (fr)
WO (1) WO2021010118A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220273732A1 (en) * 2021-02-26 2022-09-01 California Institute Of Technology Probiotic therapies for social deficit and stress response

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013544780A (ja) 2010-10-07 2013-12-19 カリフォルニア インスティチュート オブ テクノロジー 自閉症の生菌療法
US20160177424A1 (en) 2014-10-16 2016-06-23 Korea Institute Of Machinery & Materials Ni-base superalloy and manufacturing method thereof
JP2017532361A (ja) 2014-10-30 2017-11-02 カリフォルニア インスティチュート オブ テクノロジー 神経発達症群における行動の改善のための細菌含有組成物、及び細菌を使用することを含む、神経発達症群における行動の改善のための方法
JP2018502056A (ja) 2014-10-30 2018-01-25 カリフォルニア インスティチュート オブ テクノロジー 神経発達症群における行動の改善のための細菌含有組成物、及び細菌を使用することを含む、神経発達症群における行動の改善のための方法
CN108244655A (zh) 2018-02-02 2018-07-06 云南中京国建投资有限公司 一种安神、抗抑郁的合生元组合物及其制剂与应用
WO2018215759A1 (fr) 2017-05-22 2018-11-29 4D Pharma Research Limited Compositions comprenant des souches bactériennes

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013544780A (ja) 2010-10-07 2013-12-19 カリフォルニア インスティチュート オブ テクノロジー 自閉症の生菌療法
US20160177424A1 (en) 2014-10-16 2016-06-23 Korea Institute Of Machinery & Materials Ni-base superalloy and manufacturing method thereof
JP2017532361A (ja) 2014-10-30 2017-11-02 カリフォルニア インスティチュート オブ テクノロジー 神経発達症群における行動の改善のための細菌含有組成物、及び細菌を使用することを含む、神経発達症群における行動の改善のための方法
JP2018502056A (ja) 2014-10-30 2018-01-25 カリフォルニア インスティチュート オブ テクノロジー 神経発達症群における行動の改善のための細菌含有組成物、及び細菌を使用することを含む、神経発達症群における行動の改善のための方法
WO2018215759A1 (fr) 2017-05-22 2018-11-29 4D Pharma Research Limited Compositions comprenant des souches bactériennes
CN108244655A (zh) 2018-02-02 2018-07-06 云南中京国建投资有限公司 一种安神、抗抑郁的合生元组合物及其制剂与应用

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
Beneficial Microbes，2019年07月03日，Vol.10, No.6，pp.661-669
ENCK P. et al.，Neurogastroenterol Motil，2008年，Vol.20，pp.1103-1109
TSUKAHARA T. et al.，J. Vet. Med. Sci.，2007年，Vol.69, No.2，pp.103-109
TSUKAHARA T. et al.，Microbial Ecology in Health and Disease，2005年，Vol.17，pp.107-113
嶋川真木ほか，実験的過敏性腸症候群モデル（内臓痛覚過敏モデル）に対するStreptococcus faecalis 129 BIO 3Bの効果，腸内細菌学雑誌，2013年，Vol.27, No.2，p.120, 一般演題B-12

Also Published As

Publication number Publication date
JP2021014432A (ja) 2021-02-12
WO2021010118A1 (fr) 2021-01-21
KR20220034724A (ko) 2022-03-18

Similar Documents

Publication Publication Date Title
Vaiserman et al. Gut microbiota: A player in aging and a target for anti-aging intervention
JP6554730B2 (ja) ビフィドバクテリウム・ロンガム及び海馬ｂｄｎｆ発現
Etxeberria et al. Pterostilbene‐induced changes in gut microbiota composition in relation to obesity
RU2677890C2 (ru) Бактериальные штаммы, выделенные из свиней
CN113382740A (zh) 包含细菌菌株的组合物
Karimi et al. Single-species versus dual-species probiotic supplementation as an emerging therapeutic strategy for obesity
CN116286509A (zh) 新型乳酸菌及其应用
AU2016315266A1 (en) Methods and compositions using Bifidobacterium longum to treat or prevent depressive symptoms
Wiley et al. Production of psychoactive metabolites by gut bacteria
CN113286872B (zh) 胃肠道小生物群的新细菌属dysosmobacter及其用途
Stover et al. Pre-and probiotic supplementation in ruminant livestock production
JP2020520928A (ja) 細菌株を含む組成物
Zhang et al. Fructooligosaccharides supplementation mitigated chronic stress-induced intestinal barrier impairment and neuroinflammation in mice
JP7269568B2 (ja) 不安障害及び／又は気分障害を改善又は予防するための組成物
Gao et al. Ingestion of Lactobacillus helveticus WHH1889 improves depressive and anxiety symptoms induced by chronic unpredictable mild stress in mice
US20210077547A1 (en) Spore-based probiotic composition for modulation of microbiome in humans
Stevens et al. Effect of a carotenoid-producing Bacillus strain on intestinal barrier integrity and systemic delivery of carotenoids: A randomised trial in animals and humans
US20230310519A1 (en) Use of adlercreutzia bacteria for the treatment of inflammatory diseases
Chen et al. Dietary tryptophan improves growth and intestinal health by promoting the secretion of intestinal β-defensins against enterotoxigenic Escherichia coli F4 in weaned piglets
Class et al. Patent application title: Use of Bifidobacterium Animalis for Treating or Preventing Body Weight Gain and Insulin Resistance Inventors: Jian Shen (Shanghai, CN) Jingjing Wang (Shanghai, CN) Liping Zhao (Shanghai, CN) Martin Saul Obin (West Newton, MA, US) Muriel Derrien (Bures Sur Yvette, FR) Emilie Rocher (Massy, FR) Johan Van Hylckama Vlieg (Marly Le Roi, FR) Assignees: TUFTS UNIVERSITY COMPAGNIE GERVAIS DANONE
Oriach et al. Clinical Nutrition Experimental
Tanner Mechanistic study of bifidobacterium thermophilum RBL67 for Salmonella inhibition using in vitro fermentation and in vivo swine models

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20190712

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20190731

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20191111

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20200303

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20200303

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20210405

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20220412

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20220609

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220805

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20221122

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20230117

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230309

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20230404

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20230410

R150 Certificate of patent or registration of utility model

Ref document number: 7269568

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150